Tabernero, Josep http://orcid.org/0000-0002-2495-8139
Alsina, Maria
Shitara, Kohei
Doi, Toshihiko
Dvorkin, Mikhail
Mansoor, Wasat
Arkenau, Hendrik-Tobias
Prokharau, Aliaksandr
Ghidini, Michele
Faustino, Catia
Gorbunova, Vera
Zhavrid, Edvard
Nishikawa, Kazuhiro
Ando, Takayuki
Yalçın, Şuayib
Van Cutsem, Eric
Sabater, Javier
Skanji, Donia
Leger, Catherine
Amellal, Nadia
Ilson, David H.
Funding for this research was provided by:
Servier
Article History
Received: 26 October 2019
Accepted: 17 February 2020
First Online: 4 March 2020
Compliance with ethical standards
:
: Josep Tabernero reports personal fees from Array Biopharma, AstraZeneca, Bayer, BeiGene, Boehringer Ingelheim, Chugai, Genentech, Inc., Genmab A/S, Halozyme, Imugene Limited, Inflection Biosciences Limited, Ipsen, Kura Oncology, Lilly, MSD, Menarini, Merck Serono, Merrimack, Merus, Molecular Partners, Novartis, Peptomyc, Pfizer, Pharmacyclics, ProteoDesign SL, Rafael Pharmaceuticals, F. Hoffmann-La Roche Ltd, Sanofi, SeaGen, Seattle Genetics, Servier, Symphogen, Taiho, VCN Biosciences, Biocartis, Foundation Medicine, HalioDX SAS and Roche Diagnostics. Maria Alsina reports personal financial interest in form of scientific consultancy for BMS, Lilly, MSD and Servier Honorarium for speaking issues from Amgen, BMS, Lilly, MSD, Roche and Servier Travel expenses partially covered by Amgen, Lilly and Roche. Kohei Shitara reports grants and personal fees from Astellas Pharma, Lilly, Ono Pharmaceutical, and MSD; personal fees from Bristol-Myers Squibb, Takeda, Pfizer, Novartis, Abbvie, and Yakult; grants from Dainippon Sumitomo Pharma, Daiichi Sankyo, Taiho Pharmaceutical, Chugai Pharma, and Medi Science. Toshihiko Doi reports grants from Lilly, Kyowa Hakko Kirin, MSD, Daiichi Sankyo, Amgen, Sumitomo Dainippon, Taiho, Novartis, Merck Serono, Astellas, Janssen, Boehringer Ingelheim, Takeda, Pfizer, Chugai Pharma, Celegene, Bristol-Myers Squibb, Abbvie, Quintiles, Bayer, and Eisai. Hendrik-Tobias Arkenau reports personal fees from Roche, Bicycle therapeutics, BioNTech, BeiGene. Michele Ghidini reports personal fees from Lilly, Servier for advisory boards. Catia Faustino reports personal fees from Servier, Merck Serono, Ipsen, Novartis, and Astellas. Kazuhiro Nishikawa reports personal fees from Chugai Pharma, Taiho Pharmaceutical, Yakult Honsha, Bristol-Myers Squibb Japan, EA Pharma, Lilly, and Ono Pharmaceutical; grants from Taiho Pharmaceutical, and Ono Pharmaceutical. Şuayib Yalçın reports honoraria from Roche, Pfizer, Amgen, Merck Serono, and Lilly. Eric Van Cutsem has received research funding from Amgen, Bayer, Boehringer Ingelheim, Celgene, Ipsen, Lilly, Merck, Merck KgA, Novartis, Roche, Sanofi, and Servier. Javier Sabater, Donia Skanji, Catherine Leger and Nadia Amellal are employees of Servier. David Ilson has served as a consultant/advisor for Amgen, Lilly, Roche, Genentech, Astra-Zeneca, Taiho, and Pieris and has received research funding from Bristol-Myers Squibb, Bayer, Taiho, and Amgen. Mikhail Dvorkin, Wasat Mansoor, Aliaksandr Prokharau, Vera Gorbunova, Edvard Zhavrid, and Takayuki Ando have no conflicts of interest to disclose.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: Informed consent was obtained from all patients who were included in the study.